Evidence map›Paper›PMID 39881959›Full record

ReviewFrontiers in bioengineering and biotechnology2024

Approaches and applications in transdermal and transpulmonary gene drug delivery.

Anni Zhang, Xuran Zhang, Jiahui Chen, Xianbao Shi, Xijuan Yu, Zhonggui He, Jin Sun, Mengchi Sun, Zhijun Liu

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anni Zhang *Department of Ultrasound, Shengjing Hospital, China Medical University, Shenyang, Liaoning, China.
Xuran Zhang *Department of Orthopedics, Fuxin Center Hospital, Fuxin, Liaoning, China.
Jiahui Chen *School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
Xianbao ShiDepartment of Pharmacy, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.
Xijuan YuDepartment of Ultrasound, Shengjing Hospital, China Medical University, Shenyang, Liaoning, China.
Zhonggui HeWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
Jin SunWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
Mengchi SunSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
Zhijun LiuDepartment of Ultrasound, Shengjing Hospital, China Medical University, Shenyang, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene therapy has emerged as a pivotal component in the treatment of diverse genetic and acquired human diseases. However, effective gene delivery remains a formidable challenge to overcome. The presence of degrading enzymes, acidic pH conditions, and the gastrointestinal mucus layer pose significant barriers for genetic therapy, necessitating exploration of alternative therapeutic options. In recent years, transdermal and transpulmonary gene delivery modalities offer promising avenues with multiple advantages, such as non-invasion, avoided liver first-pass effect and improved patient compliance. Considering the rapid development of gene therapeutics via transdermal and transpulmonary administration, here we aim to summarize the nearest advances in transdermal and transpulmonary gene drug delivery. In this review, we firstly elaborate on current delivery carrier in gene therapy. We, further, describe approaches and applications for enhancing transdermal and transpulmonary gene delivery encompassing microneedles, chemical enhancers, physical methods for transdermal administration as well as nebulized formulations, dry powder formulations, and pressurized metered dose formulations for efficient transpulmonary delivery. Last but not least, the opportunities and outlooks of gene therapy through both administrated routes are highlighted.

Indexed as

approaches and applicationscurrent delivery carriergene therapyopportunities and outlookstransdermal gene deliverytranspulmonary gene delivery

Identifiers

PMID39881959
PMCPMC11775749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.